Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Mohamed Zaid

Matched on ORCID iD 0000-0002-8615-2456; OpenAlex author ID A5046059508. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
72
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 3 papers

Papers 11

  1. Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2022.04.044↗
  2. Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreati… First author DOI 10.1016/j.ijrobp.2022.06.089↗
  3. Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2021.12.273↗
  4. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.pan.2020.11.003↗
  5. Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Ea… Co-author DOI 10.3389/fonc.2020.596931↗
  6. Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study. Co-author DOI 10.3390/cancers12123656↗
  7. Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1200/po.19.00001↗
  8. Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer. Co-author DOI 10.15252/emmm.201910515↗
  9. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therap… First author DOI 10.1002/cncr.31251↗
  10. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-17-3668↗
  11. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2017.06.026↗

Closest collaborators

The 25 strongest of 72 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eugene Jon Koay · 10 shared papers, 2017–2022 · strength 0.82
  2. Anirban Maitra · 8 shared papers, 2018–2022 · strength 0.70
  3. Matthew H. G. Katz · 7 shared papers, 2018–2022 · strength 0.60
  4. Huamin Wang · 7 shared papers, 2018–2022 · strength 0.60
  5. Robert A. Wolff · 7 shared papers, 2018–2022 · strength 0.60
  6. Eric Peter Tamm · 7 shared papers, 2018–2022 · strength 0.56
  7. Priya Bhosale · 6 shared papers, 2018–2022 · strength 0.48
  8. Gauri Rajani Varadhachary · 6 shared papers, 2018–2022 · strength 0.48
  9. Christopher H. Crane · 5 shared papers, 2018–2022 · strength 0.40
  10. Jeffrey E. Lee · 5 shared papers, 2018–2022 · strength 0.39
  11. Cullen M. Taniguchi · 4 shared papers, 2018–2022 · strength 0.33
  12. Joseph M. Herman · 3 shared papers, 2018–2022 · strength 0.26
  13. Michael P. Kim · 3 shared papers, 2018–2022 · strength 0.26
  14. Yeon‐Ju Lee · 4 shared papers, 2017–2019 · strength 0.24
  15. Sunil Krishnan Krishnan · 3 shared papers, 2018–2022 · strength 0.23
  16. Milind M. Javle · 3 shared papers, 2018–2022 · strength 0.23
  17. Albert C. Koong · 2 shared papers, 2022 · strength 0.22
  18. Grace L. Smith · 2 shared papers, 2022 · strength 0.22
  19. Ching-Wei David Tzeng · 2 shared papers, 2021–2022 · strength 0.21
  20. Aatur Dilip Singhi · 2 shared papers, 2020–2022 · strength 0.21
  21. Abdel Nasser Hosein · 2 shared papers, 2019–2022 · strength 0.21
  22. Jason B. Fleming · 3 shared papers, 2018–2019 · strength 0.18
  23. Laura R. Prakash · 2 shared papers, 2019–2021 · strength 0.18
  24. Michael James Overman · 2 shared papers, 2018–2022 · strength 0.16
  25. Takashi Okumura · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.